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Peritoneal implantation from hepatocellular carcinoma has been rarely reported. It may occur at various sites. Here we present
a surgically resected case of peritoneal implantation to the diaphragm from hepatocellular carcinoma. A 50-year-old woman
underwent right hemihepatectomy extended to a medial part of Couinaud segment IV for hepatocellular carcinoma in May 2000.
In December 2008, the elevation of alpha-phetoprotein and the appearance of a heterogeneously enhanced mass, with dimensions
of 9 × 7cm, and adjacent to the remnant liver and pericardium suggested intrahepatic recurrence with markedly enhanced
growth. After transcatheter arterial embolization, surgical resection under laparotomy combined with median sternotomy was
selected. Samples of pericardial ﬂuid showed no malignancy after cytological examination. At the superior border of the tumor,
the conﬂuence of pericardium and diaphragm was displaced, but the tumor itself showed a generally expanding but not invasive
growth. The resected tumor showed moderately diﬀerentiated hepatocellular carcinoma whose pathology revealed a peritoneal
implantation to the diaphragm. The patient is in good health without any postoperative complications or any further sign of
recurrence.
Copyright © 2009 Yuichi Sanada et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Hepatocellular carcinoma (HCC) is the most preventable
type of liver carcinoma in the world. Hepatitis virus-
related cirrhosis is known as the leading cause of HCC
carcinogenesis. The prognosis is poor while surgery remains
the best curative therapy, because the recurrence rate is
quite high even after complete resection. The recurrence in
almost all cases is usually detected in the remnant liver, and
then the tendency is for secondaries to be found in lung
or bone [1]. Therefore, peritoneal recurrence from HCC
in clinical settings is rare, accounting for 2%–16% of cases
[1]. Furthermore, recent reports have demonstrated that
peritoneal recurrence is mainly observed on the omentum or
serosal surface of the intestine [2, 3]. Because the recurrent
tumor in this case appeared adjacent to the remnant liver,
this solitary peritoneal recurrence of the tumor might be
recognized as intrahepatic recurrence.
Here we report a case of solitary peritoneal implantation
inthediaphragmduetoHCC,andthepreoperativeimaging,
the histopathologic ﬁndings of the resected specimen, and
the surgical procedure selected will be discussed with a
review of the literature.
2.CaseReport
A 50-year-old woman positive for hepatitis B virus under-
went a right hemihepatectomy extended to a medial part
of Couinaud segment IV for HCC in May 2000. The
initial tumor was mainly located in Couinaud segment V
and was 10cm in diameter with capsule invasion. Histo-
logically, it was moderately diﬀerentiated HCC with thick
trabecular pattern with microscopic vascular invasion. In
January 2001, partial resection of the medial segment was
performed due to recurrence in the form of intrahepatic
metastasis. During a period of 8 years after second surgery,
no recurrence sign was detected by 5-year regular imaging
follow-up at our hospital. In December 2008, the patient
consulted a home doctor for chest discomfort and then
was recommended to our hospital again for the purpose of2 Journal of Oncology
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Figure 1: Preoperative ﬁndings. CT shows a heterogenous mass ((a)–(c), arrow), 9cm in diameter adjacent to the remnant liver (a),
displacing the IVC (b) and the pericardium (c). Angiography shows that the remnant liver is supplied by the left hepatic artery (d). Selective
angiogramsshowahypervasculartumorsuppliedfromthedescendingbranchoftheinferiorphrenicartery(IPA)(e)andthephrenicbranch
of the internal mammary artery (IMA) (f).
generalexamination. The serumvalue of alpha-phetoprotein
(AFP)increasedto248369ng/mL(normalrage;<20ng/mL).
Computed tomography (CT) revealed a heterogenous mass,
9 × 7cm in diameter, in the remnant liver (Figure 1(a)).
The mass had expanded to the adjacent organs, inferior vena
cava (IVC) (Figure 1(b)) and the pericardium (Figure 1(c)),
indicating a diagnosis of intrahepatic recurrence from HCC.
Angiography revealed that the remnant liver was supplied by
lefthepaticarterywithnotumorstain(Figure 1(d)).Because
selectiveangiogramsshowedahypervasculartumorsupplied
from the descending branch of the inferior phrenic artery
(IPA) (Figure 1(e)) and the phrenic branch of the internal
mammary artery (IMA) (Figure 1(f)), transcatheter arterial
embolization (TAE) was selected ﬁrst. However, TAE could
not relieve her chief complaint, and after evaluation that
there were no other distant metastases, complete surgical
resection was planned on January 2009. Because it was
diﬃcult to identify the whole aspect of the tumor from just
the abdominal upper midline incision, an additional median
sternotomy was carried out (Figures 2(a) and 2(b)). Pericar-
dial ﬂuid was found to have no malignancy after cytological
examination. At the superior border of the tumor, the con-
ﬂuenceofthepericardiumanddiaphragmwasdisplaced,but
the tumor itself showed general expanding growth that was
not invasive. Since the adhesion on the central tendon was
too complete to separate, the crus was ligated (Figure 2(c)).
The diaphragm was divided toward the left edge of the
sternocostal trigone, and when rotated, the heart was
observed. In the opened pericardial cavity, the pericardium
was transected to expose the posterior side of the tumor
from the IVC (Figure 2(d)), and following transection of the
posterior parietal peritoneum, the specimen was removed
(Figure 2(e)). The diaphragm was sutured and the defect
in the pericardium was repaired using a composix mesh
(Figures 2(f)–2(h)). Macroscopically, the resected tumor, at
9.5 × 7.4cm(Figure 3(a)), was covered with ﬁbrous tissue
(diaphragm) without evidence of inﬁltration and expansive
necrosis was detected (Figure 3(b)). The tumor comprised
moderately diﬀerentiated HCC showing a thick trabecular
pattern and focal pseudogland formation (Figure 3(c))a n d
also the displaced muscular layer of the diaphragm was
observed (Figure 3(d), arrow). These histological ﬁndings
revealed a solitary peritoneal implantation to the diaphragm.
The surgical resection could relieve her chest discomfort
immediately. The patient is in good health without any
postoperative events and no sign of recurrence.Journal of Oncology 3
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Figure 2: Images and schematic presentations of operative ﬁndings and procedures. By opening the pericardium, the tumor was found to be
located between the remnant liver and the heart, and the diaphragm was displaced to the upper side ((a), (b)). Due to a median sternotomy
with opening of the pericardium, the tumor was pulled to the right (c). The pericardium was divided from the dorsal aspect of the tumor to
the left wall of the IVC (d). A complete resection can be achieved (e). Defects of the diaphragm and the pericardium were repaired ((f)–(h)).
3. Discussion
The recurrence from HCC is usually detected in the remnant
liver and as secondary metastases in the lung or bone. In
spite of the preoperative diagnosis as an intrahepatic mass,
two doubts, the markedly extrahepatic growth formation
and feeding routs depending on IPA and IMA, were
indicated. The IPA is known as the most common source
of extrahepatic collateral blood supply for HCC [4], and
the IMA is demonstrated to develop as a collateral vessel
after ligation of the hepatic artery [5]. And IMA enters
the liver from the hepatic falciform ligament to supply the
left lobe and HCCs located in S4 have been reported to
feed from the right IMA [6]. In the present case, after two
episodes of surgery, the arterial supply was suspected to
have changed. However, both the operative ﬁndings and4 Journal of Oncology
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Figure 3: Resected specimen. The tumor is covered with the diaphragm at the cranial edge with no inﬁltration (a). The cut surface shows
focal necrosis induced by preoperative TAE (b). The tumor is composed of moderately diﬀerentiated HCC with a thick trabecular pattern
(c). The diaphragm is displaced with no inﬁltration to the muscular layer ((d), arrow).
pathological evaluation clearly indicated that the tumor
arose from the diaphragm as a solitary peritoneal recurrence.
This quite rare recurrence pattern will be discussed. It is
diﬃcult to clarify that this huge tumor was a peritoneal
implantation or hematogenous metastasis to the diaphragm.
In the present case, the recurrent site was adjacent to
the resection margin of initial hepatectomy. In addition,
histologically, resected tumor was localized in the peritoneal
layer of the diaphragm with no inﬁltration to the muscular
layer of the diaphragm. Therefore, it seems reasonable to
suppose that the recurrent pattern of the present case is
peritoneal implantation. However, the image ﬁndings and
pathologic ﬁndings in the present case remind us of the
possibility for ectopic HCC in the diaphragm. Ectopic HCC
is very rarely reported [7,8].Althoughweareincompetentto
discuss this possibility, it is a valid assumption that this huge
tumor is a peritoneal implantation because the normal liver
parenchyma could not be identiﬁed throughout the resected
specimen.
The mechanism of peritoneal implantation from HCC
is suggested to occur following rupture or invasion to the
peritoneal cavity through the liver surface [9]. The hepatoma
cells usually need a full blood supply to achieve growth, and
so peritoneal implantation has been believed to be quite rare
[1]. A recently published review has demonstrated that only
one case of peritoneal recurrence to the diaphragm from
HCC was identiﬁed out of 24 cases [2]. From the evidence
that hepatitis B virus-based hepatoma related to peritoneal
recurrence compared with other type of virus [10]. Li et al.
pointed out that patients with HCV infection tended to be
older and were characterized by more severe cirrhosis and
higher incidence of tumor multicentricity [11], while Huo
etal.reportedthatpatientsintheHBVgroupmoreoftenhad
ah i g h e rt o t a lt u m o rv o l u m e[ 12]. Although the incidence
of peritoneal recurrence in HCC associated with HBV virus
is unclear, these descriptions suggest that patients with
HCC associated with the hepatitis B virus have a potential
for locally exophytic growth. Accordingly, in patients with
hepatitis B virus, we should pay attention to recurrent forms
other than intrahepatic recurrence or distant metastasis.
According to a study of 16 cases with peritoneal recurrence
[10], the serosal surface of the bowel or the omentum was
targeted, and there were no cases with recurrence on the
diaphragm. In our patient, two episodes of surgery might
have supported a full blood supply to hepatoma cells on the
diaphragm during the stages of healing.Journal of Oncology 5
It has been reported that the 1-, 3-, and 5-year survival
rates after resection of peritoneal recurrence of HCC were
62.5%, 34.1%, and 30.1%, respectively, and the presence of
capsule invasion was found to be the most signiﬁcant prog-
nosticfactor[10].However,duetotherarityofthisrecurrent
form there have been no studies of the postoperative
prognosis betweenperitonealrecurrenceandotherrecurrent
forms. Poon et al. [13] reported that an aggressive strategy
is likely to be more favorable for patients with solitary
extrahepatic recurrence. In the present case, fortunately, the
peritoneal tumor with capsule was detected as solitary and
developed expansively to the diaphragm. According to the
usual interval for the appearance of peritoneal recurrence,
which ranges from 0 to 84 months [2], the present case is
a notable long-term recurrence after the initial surgery. The
long interval between initial surgery and recurrence in the
present case suggests the low malignant behavior. Nakayama
et al. reported that resection of peritoneal recurrence arising
from HCC may be of value in improving patient survival
[14]. However, it is still unclear whether this variation in the
interval of peritoneal recurrence has diﬀerent implications
for prognosis after resection. Due to disappointing outcomes
from chemotherapy for HCC [15], it is necessary to diagnose
new tumors by regular examination and to treat them with
aggressive surgical procedures.
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